NPI 1508985359: Open Payments
NPI 1508985359. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$696 in 6 payments from 3 companies in 2025. Trend: 2023 $354 · 2024 $1,043 · 2025 $696
Food & beverage: $696
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $371 |
| Abbott Laboratories | 2 | $168 |
| Kestra Medical Technology Services, Inc. | 1 | $158 |
Products named: FREESTYLE LIBRE 3, Assure WCD, Ozempic, Wegovy.
